Maravai Lifesciences Holdings (MRVI) Other Non-Current Liabilities (2020 - 2026)

Maravai Lifesciences Holdings' Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $36.1 million for Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 17.95% year-over-year to $36.1 million in Q1 2026; TTM through Mar 2026 was $36.1 million, a 17.95% decrease from a year earlier, with the FY2025 full-year figure at $36.5 million, down 30.47% from the prior year.
• Other Non-Current Liabilities slipped to $36.1 million in Q1 2026 per MRVI's latest filing, from $36.5 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $66.5 million in Q1 2022 and bottomed at $10.0 million in Q4 2022.
• The 5-year median for Other Non-Current Liabilities is $54.0 million (2024), against an average of $50.0 million.
• Across the five-year window, Other Non-Current Liabilities surged 4686.19% in 2022 and tumbled 30.47% in 2025, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $10.0 million in 2022, then soared by 494.94% to $59.5 million in 2023, then fell by 11.81% to $52.5 million in 2024, then sank by 30.47% to $36.5 million in 2025, then decreased by 1.11% to $36.1 million in 2026.
• Per Business Quant, the three latest MRVI Other Non-Current Liabilities figures stand at $36.1 million (Q1 2026), $36.5 million (Q4 2025), and $38.0 million (Q3 2025).